SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-065218
Filing Date
2019-03-06
Accepted
2019-03-06 13:11:06
Documents
6
Effectiveness Date
2019-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 d698213ds8.htm S-8 41980
2 EX-5.1 d698213dex51.htm EX-5.1 7461
3 EX-23.1 d698213dex231.htm EX-23.1 1485
4 GRAPHIC g698213g30e83.gif GRAPHIC 4599
5 GRAPHIC g698213g38d53.gif GRAPHIC 2144
6 GRAPHIC g698213g39b30.gif GRAPHIC 2968
  Complete submission text file 0001193125-19-065218.txt   65800
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230092 | Film No.: 19661918
SIC: 2834 Pharmaceutical Preparations